SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-012156
Filing Date
2022-02-23
Accepted
2022-02-23 16:05:48
Documents
1
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4155
  Complete submission text file 0001209191-22-012156.txt   5625
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
Blouse Grant E. (Reporting) CIK: 0001869883 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 22663480